Recent Updates
Recently added Catalysts
KEQU

Unassociated Document Kewaunee Scientific Announces Results for Third Quarter and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC

Key Takeaway: Scientific Announces for Third Quarter and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 NC, February 25, 2010--Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2010. the qu

Full Press Release Details

Scientific Announces
for Third Quarter and Quarterly Dividend
Exchange: NASDAQ (KEQU) Contact: D. Michael Parker
704/871-3290
NC, February 25, 2010--Kewaunee Scientific Corporation (NASDAQ: KEQU) today
announced results for its third quarter ended January 31, 2010.
the quarter were $21,814,000, down from sales of $26,023,000 in the same period
last year. Sales were affected by a soft market for small laboratory
furniture projects, lower sales to international customers, and unusually bad
weather which delayed the start of many construction projects. The
lower sales also reflect the typical slowdown in construction activity during
the winter months, which did not occur last year. Sales from domestic
operations during the quarter were $19,081,000, down from sales of $22,498,000
in the same period last year. Sales from international operations
were $2,733,000, down from sales of $3,525,000 in the same period last
backlog increased to a record $65.5 million at January 31, 2010, up from $60.7
million at January 31, 2009, and $65.2 million at the end of last
earnings for the quarter were $621,000, or $0.24 per diluted share, down from
$882,000, or $0.35 per diluted share, in the same period last year. Earnings
were unfavorably impacted by lower sales and an after-tax increase in pension
expense of $157,000, or $0.06 per diluted share, as compared to the third
quarter last year. The pension expense increase primarily resulted
from last year's decline in the market value of pension
the lower earnings, I am pleased with our progress during the quarter,"
said William A. Shumaker, President and Chief Executive Officer. "The
order backlog is strong at $65.5 million, and outstanding quotations are at
record levels. Quotation opportunities in the international
marketplace have increased dramatically in recent months. The
international marketplace appears to show signs of recovery from the economic
slowdown, and we expect to see improved results from our international
operations in the fourth quarter. Quotation activity also remains
strong in the domestic marketplace for larger laboratory projects, although we
expect our results in the short-term will continue to be impacted by changes to
construction schedules and project delivery dates. All of our markets remain
highly-competitive with aggressive pricing; however, we continue to successfully
compete and win projects."
the nine months ended January 31, 2010 were $75,151,000, down from sales of
$79,150,000 in the same period last year. Domestic sales for the nine months
ended January 31, 2010 were $67,152,000, down from sales of $67,296,000 in the
same period last year. Sales from international operations were
$7,999,000 for the nine months ended January 31, 2010, down from sales of
$11,854,000 in the same period last year.
earnings for the nine months ended January 31, 2010 were $3,044,000, or $1.18
per diluted share, down from net earnings of $3,327,000, or $1.30 per diluted
share, in the same period last year. Earnings for the nine months
were unfavorably impacted by an after-tax increase in pension expense of
$470,000, or $0.18 per diluted share, as compared to the same period last
Company's financial condition continues to be strong. Bank borrowings and
capital lease obligations decreased to $3,144,000 at January 31, 2010, down from
$6,318,000 at January 31, 2009. Cash on hand was $2,443,000, as compared to
$3,089,000 at the end of the same period last year. Working capital increased to
$21,327,000 at the end of the quarter, up from $17,749,000 at the end of the
same period last year.
look forward, I am optimistic about Kewaunee's future," continued Mr.
Shumaker. "Our strategies to expand into new markets, introduce new
products, and reduce costs are positioning Kewaunee well for long-term growth
and success. We also continue to expand our manufacturing
capabilities, with the recently announced expansion of our Statesville facility
following the move into our new, larger Bangalore factory last
news, the Company announced today that its Board of Directors approved a cash
dividend of ten cents per outstanding share to stockholders of record at the
close of business on March 8, 2010, payable on March 22, 2010.
Scientific Corporation is a recognized leader in the design, manufacture, and
installation of scientific and technical furniture. The Company's corporate
headquarters are located in Statesville, North Carolina. The Company's
manufacturing facilities are located in Statesville and Bangalore, India. The
Company has subsidiaries in Singapore and Bangalore that serve the Asian and
Middle East markets. Kewaunee Scientific's website is located at
statements in this release constitute "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and
Statements of Operations
thousands, except per share data)
Three Months Ended Nine Months Ended
January 31 January 31
2010 2009 2010 2009
Net sales $ 21,814 $ 26,023 $ 75,151 $ 79,150
Cost of products sold 17,129 21,089 58,492 62,846
Gross profit 4,685 4,934 16,659 16,304
Operating expenses 3,663 3,440 11,605 10,884
Operating earnings 1,022 1,494 5,054 5,420
Other expense -- 3 -- (36 )
Interest expense (35 ) (49 ) (115 ) (231 )
Earnings before income taxes 987 1,448 4,939 5,153
Income tax expense 333 488 1,673 1,595
Net earnings 654 960 3,266 3,558
Less; net earnings attributable to
the noncontrolling interest 33 78 222 231
Net earnings attributable to
Kewaunee Scientific Corporation $ 621 $ 882 $ 3,044 $ 3,327
Net earnings per share attributable to
Kewaunee Scientific Corporation stockholders
Basic $ 0.24 $ 0.35 $ 1.19 $ 1.30
Diluted $ 0.24 $ 0.35 $ 1.18 $ 1.30
Weighted average number of common
shares outstanding (in thousands)
Basic 2,569 2,556 2,562 2,554
Diluted 2,581 2,556 2,570 2,563
Consolidated Balance Sheets
January 31 April 30
2010 2009
(unaudited)
Assets
Cash and cash equivalents $ 1,937 $ 3,559
Restricted cash 506 456
Receivables, less allowances 23,007 24,526
Inventories 7,924 7,839
Prepaid expenses and other current assets 1,585 1,165
Total current assets 34,959 37,545
Net property, plant and equipment 12,609 11,369
Other assets 4,035 3,615
Total Assets $ 51,603 $ 52,529
Liabilities and Stockholders' Equity
Short-term borrowings $ 2,909 $ 5,720
Current obligations under capital leases 96 220
Accounts payable 6,082 8,812
Other current liabilities 4,545 3,911
Total current liabilities 13,632 18,663
Other non-current liabilities 6,672 5,607
Total liabilities 20,304 24,270
Noncontrolling interest 1,625 1,306
Kewaunee Scientific Corporation equity 29,674 26,953
Total equity 31,299 28,259
Total Liabilities and Equity $ 51,603 $ 52,529
Last updated: Feb 25, 2010